Genetics and Rare Disease in Saudi Arabia: AI Notes for Complex Genetic Cases

Category: Clinical Workflow & Specialty Guides | Market: Saudi Arabia | Keywords: Saudi Arabia genetics rare disease AI notes complex genetic cases documentation

Saudi Arabia has one of the highest consanguinity rates in the world — first-cousin marriages are common in many Saudi regions — which significantly elevates the prevalence of autosomal recessive conditions. Saudi Arabia is also home to one of the world's most active rare disease research and clinical programmes, led by King Faisal Specialist Hospital and Research Centre's Department of Medical Genetics and at King Abdulaziz University and other institutions. The complexity of genetics consultations — covering molecular diagnoses, genetic counselling, family pedigree analysis, and management of multisystem rare diseases — makes genetics documentation among the most challenging in clinical medicine. AI medical scribing is becoming essential in Saudi genetics departments.

## The Saudi Genetics Burden

The elevated consanguinity rate in Saudi Arabia produces higher-than-expected population frequencies of autosomal recessive conditions including haemoglobin disorders (sickle cell disease, beta-thalassaemia), lysosomal storage diseases, metabolic disorders, primary immunodeficiencies, deafness, and skeletal dysplasias. Saudi Arabia's Newborn Screening Programme — one of the most comprehensive in the Middle East — identifies affected neonates early, generating a large follow-up population managed by clinical genetics and metabolic disease services. Additionally, Saudi Arabia's investment in genomic medicine through the Saudi Human Genome Programme has expanded molecular diagnostic capacity significantly.

## Genetics Consultation Documentation

• Presenting indication: reason for genetics referral — developmental delay, dysmorphic features, positive newborn screen, family history of genetic disease, consanguineous couple, or recurrent pregnancy loss.

• Family history and pedigree: three-generation pedigree with health status of all family members, consanguinity, affected individuals, and causes of death — this is the cornerstone of genetic assessment documentation.

• Clinical assessment: dysmorphic feature documentation (growth parameters, facial features, body proportions), developmental milestone assessment, and organ system review for multisystem involvement.

• Genetic investigation results: chromosomal microarray, whole exome/genome sequencing, specific gene panel, metabolic biochemistry — with variant interpretation and ACMG pathogenicity classification.

• Genetic counselling documentation: inheritance pattern explanation, recurrence risk, prenatal diagnosis options, and the patient's or family's understanding and decisions.

## AI Scribing in Saudi Clinical Genetics

Pedigree and family history capture. The construction of an accurate three-generation pedigree from the clinical interview is fundamental to genetic diagnosis. AI scribing captures the family history interview systematically, generating pedigree information in a structured format that can be converted to a formal pedigree diagram.

Variant interpretation documentation. When molecular results return, the genetics consultation includes detailed explanation of variant findings — pathogenic, likely pathogenic, variant of uncertain significance — with the clinical implications. AI scribing captures this nuanced interpretation discussion completely.

Prenatal counselling records. Genetic counselling for prenatal diagnosis — chorionic villus sampling, amniocentesis, preimplantation genetic testing — requires careful documentation of the options presented, the risks of each, and the couple's informed decision. AI scribing captures this sensitive consultation completely.

## Rare Disease Multidisciplinary Documentation

Many Saudi rare disease patients require multidisciplinary management involving genetics, metabolic medicine, neurology, cardiology, and orthopaedics. MDT records for rare disease patients — discussing diagnosis, surveillance, enzyme replacement therapy, or substrate reduction therapy decisions — generated by AI scribing ensure that the complex decision-making of rare disease care is documented accurately and completely.

## Conclusion

Saudi clinical genetics services managing one of the world's most complex rare disease burdens — driven by high consanguinity and the Saudi Human Genome Programme's expanding molecular diagnostic capability — require documentation tools that match the clinical complexity of genetics consultations with documentation efficiency. AI medical scribing captures complete pedigrees, variant interpretation discussions, genetic counselling records, and MDT decisions from clinical encounters, enabling Saudi geneticists to focus on the diagnostic and counselling work that requires their unique expertise.

Internal links: Sickle Cell Disease GCC AI Documentation, Neonatology GCC AI Notes NICU High Risk Newborn, Oncology Saudi Arabia MDT Notes Chemotherapy AI, Rheumatology Saudi Arabia Autoimmune AI Documentation